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Letters to the EditorNKT cells in liver ﬁbrosis: Controversies or complexitiesTo the Editor:
We read with great interest a recent article in the Journal of Hepa-
tology by Ishikawa et al. investigating the role of CD1d-restricted
natural killer T (NKT) cells in thioacetamide (TAA)-induced liver
ﬁbrosis, by using CD1d knockout (KO) mice that are associated
with NKT cell deﬁciency [1]. First, the authors observed that
CD1d KO mice were resistant to TAA-induced liver inﬂammation,
damage, and hepatocyte apoptosis. Second, the authors observed
CD1d KO mice were resistant to TAA-induced liver ﬁbrosis, indi-
cating that NKT cells play an important role in promoting liver
ﬁbrogenesis in mice after chronic TAA treatment. The pro-ﬁbrotic
effects of NKT cells were also recently suggested by the data from
a murine model of HBV transgenic mice [2], primary biliary cir-
rhosis [3], nonalcoholic steatohepatitis (NASH), and patients with
NASH [4].
Recently, we identiﬁed the double sword face of invariant
NKT (iNKT, type I NKT) cells in liver ﬁbrogenesis in a model
of CCl4-induced liver injury [5]. On the one hand, iNKT-deﬁ-
cient mice had increased liver injury and ﬁbrosis, especially
in the early stage of CCl4-induced liver injury, suggesting that
natural activation of iNKT cells by endogenous lipid antigens
plays a protective role in preventing CCl4-induced liver injury
and ﬁbrosis. On the other hand, strong activation of iNKT cells
by a-galactosylceramide (a-GalCer) accelerated CCl4-induced
hepatocellular injury and subsequently enhanced ﬁbrosis. Our
ﬁndings clearly suggest a complex role of iNKT cells in liver
ﬁbrosis: inhibiting liver ﬁbrosis via the suppression of HSC
activation or indirectly promoting liver ﬁbrosis via enhancing
liver injury. We believe that the ﬁnal effect of iNKT cells on
liver ﬁbrosis is determined by the balance between the inhib-
itory and stimulatory effects as we discussed above, but may
also dependent on the real context of developing stage human
liver diseases or animal models used. In addition to iNKT (type
I NKT) cells, other subtypes of NKT cells including type II and
possible type III NKT cells also exist [6]. These different sub-
types of NKT cells exert many similar functions but may also
exert some opposing functions, which further complicates the
role of NKT cells in liver ﬁbrogenesis [6,7].
In the study by Ishikawa et al. [1], it appears that CD1d
restricted NKT cells play an important role in inducing liver
injury, which may contribute to the pro-ﬁbrotic effects of NKTJournal of Hepatology 2011cells observed in the TAA-induced liver injury model. In the Sup-
plementary material, Ishikawa et al. [1], reported that CD1d KO
mice were also resistant to CCl4-induced acute liver injury; how-
ever, we found that CD1d KO mice had similar liver injury and
ﬁbrosis after chronic treatment with CCl4 (Park et al., unpublished
data). Further studies are required to clarify the complex role of
NKT cells in liver injury and ﬁbrosis.
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*E-mail address: whua@mail.nih.gov (H. Wang)Reply to: ‘‘NKT cells in liver ﬁbrosis: Controversies or complexities’’
To the Editor:
Emerging attention has been paid to the role of natural killer T
(NKT) cells in a variety of liver diseases including nonalcoholic
steatohepatitis (NASH) [1]. The role of NKT cells in hepatic ﬁbro-
genesis, however, has been controversial [2–4]. In our latest man-
uscript entitled ‘‘CD1d-restricted natural killer T cells contributevol. 55 j 1162–1168
